GIFFIN BRETT A. (Chief Commercial Officer) sold 36.4% of their position (1.29K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $2.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/22/2022ACC: 0000899243-22-036695
Officer· Chief Commercial Officer
Since Nov 2021
-1.29K
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.33K acquired · 4.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.33K
Price / share
—
Trade value
—
% of position
1572.2%
11/8/2022
212.00→3.54K
Common Stock
Direct
Shares
−1.29K
Price / share
$1.79
Trade value
$2.32K
% of position
36.4%
11/10/2022
3.54K→2.25K
Total
Net shares
+2.04K
Net value
-$2.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/8/2022 | M · Option Exercise | +3.33K | — | — | 1572.2% | 212.00 | 3.54K |
| Common Stock Direct | 11/10/2022 | S · Sale | −1.29K | $1.79 | $2.32K | 36.4% | 3.54K | 2.25K |
| Total | +2.04K | -$2.32K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.33K shares
Shares
−3.33K
Strike price
Held after
6.67K
Exercisable
—
11/8/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.33K shares | 11/8/2022 | M · Option Exercise | −3.33K | — | 6.67K |